Trial Profile
A Phase 2, Pilot, Open-label, Randomized Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult Hospitalized Subjects With Confirmed Influenza Infection
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 08 Mar 2017
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections; Respiratory tract infections
- Focus Therapeutic Use
- 15 Feb 2016 New trial record